Comparision of IV dexamethasone and dexmedetomidine for prolonging the duration of analgesia after single shot interscalene brachial plexus block for arthroscopic shoulder surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002569

Enrollment

Registered

2017-12-01

Start date

2017-08-10

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

normal saline 50ml 3) D2: dexamethasone 0.11 mg/kg in 0.9&#37

normal saline 50ml+ dexmedetomidine 1.0mcg/kg in 0.9&#37

Drug : 1) Control: 0.9&#37

normal saline 50ml + 0.9&#37

normal saline 50ml ???? 2) D1: dexamethasone 0.11 mg/kg in 0.9&#37

normal saline 50ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult (Age>19 or =19) Unilateral arthroscopic shoulder surgery under general anesthesia American society of anesthesiologist status I,II,III Successful interscalene brachial plexus block whithin 30 minutes

Exclusion criteria

Exclusion criteria: American society of anesthesiologist status IV or V Pediatrics (Age<18years), Age>70 years pregnancy coagulopathy, unstable coronary artery disease, congestive heart failure, arrythmia, cardiomyopathy cerebrovascular disease systemic infection, infection at block procedure site chronic pain disorder severe pulmonary disease Neurologic deficit or neuropathy affecting the brachial plexus Refusal to participate this study Allergy to drug psychiatric disease Receiving sparfloxacine

Design outcomes

Primary

Measure	Time frame
Time to first analgesic request	—

Secondary

Measure	Time frame
Motor block duration, pain score, opioid consumption, blood glucose level, duration of sedation, satisfaction, pruritus, sleep disturbance, block-related neurologic symptoms, postoperative nausea and vomiting	—

Countries

Korea, Republic of

Contacts

Public ContactRyungA Kang

Samsung Medical Center

ryunga.kang@gmail.com+82-2-3410-0369

Outcome results